Bargain hunters should note recent insider buying trends, as they often indicate confidence in a company’s future.
On Thursday, September 11, CFO Maged Shenouda of Relmada Therapeutics purchased 200,000 shares of RLMD for $4.22 each, totaling approximately $843,990. His investment is currently up about 10.2% based on a trading high of $4.65. Over the past year, Shenouda has invested a total of $1.15 million in RLMD at an average price of $2.24 per share.
On the same day, CEO John Fieldly of Celsius Holdings bought 18,000 shares at $27.44 each, amounting to $493,843. Prior to this purchase, he had made another investment of $248,826 at $29.36 a share within the past year. Celsius Holdings is currently up about 3.6% in trading on Friday.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
